Zota Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Re. 1 per equity share.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zota Health Care Limited's Board meeting on May 22, 2026 approved three key items. First, a final dividend of Rs. 1 per equity share (10% on Rs. 10 face value) is recommended for FY 2025-26, pending shareholder approval at the AGM. Second, the Board approved standalone and consolidated audited financial results showing strong growth - standalone revenue rose 61% year-on-year to Rs. 257.28 crores with net profit of Rs. 28.79 crores (EPS Rs. 8.48). Consolidated revenue jumped 84% to Rs. 538.66 crores, though the group reported a net loss of Rs. 12.89 crores due to losses in subsidiaries. Third, the company approved subscription to 39,794 equity shares of Davaindia Health Mart Limited through a rights issue, strengthening its wholly-owned subsidiary that operates the Davaindia Generic Pharmacy retail chain with annual turnover of Rs. 267.71 crores.
The modest 10% dividend signals a balanced approach - rewarding shareholders while retaining capital for growth. The strong standalone profit growth is positive for the parent company valuation, though investors should note the consolidated losses from subsidiaries and the significant working capital stress (trade receivables up Rs. 72.54 crores) visible in the cash flow statement.